- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Pentadecapeptide (BPC) · Educational Resource
Understanding BPC-157 and Tissue Repair Research
Body Protection Compound
(Synthetic Pentadecapeptide)
Investigational Application
Tissue repair, anti-inflammatory research
Administration Protocol
Subcutaneous (subQ), per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Pentadecapeptide (BPC) · Educational Resource
Understanding BPC-157 and Tissue Repair Research
01 — Overview
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide (a chain of 15 amino acids) derived from a protective protein originally identified in human gastric juice, and is studied under the informal name 'Body Protection Compound.'
As an investigational compound, BPC-157 has not received regulatory approval for therapeutic use in the Philippines or elsewhere. The overwhelming majority of existing literature is limited to preclinical, animal-model research.
Within research literature, BPC-157 is most frequently studied for its relationship to tissue repair, angiogenesis, and anti-inflammatory pathways, areas summarized further below.
02 — How it works
How It Works: Angiogenesis Promotion and Tissue Repair Signaling
BPC-157 is studied for its ability to promote angiogenesis, the formation of new blood vessels, which researchers associate with accelerated delivery of repair factors to injured tissue sites in preclinical models.
Literature also describes BPC-157's studied interaction with nitric oxide signaling pathways and growth factor expression, positioning it within a research category focused on tissue-protective and reparative mechanisms.
Administration in Research
In preclinical literature, BPC-157 is evaluated as a subcutaneous injection administered within controlled research protocols. As an investigational compound, it has not received regulatory approval for therapeutic use, and research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Preclinical literature evaluates BPC-157 across several key physiological parameters to map its biological interactions:
Angiogenesis Signaling Pathways
Research literature evaluates how BPC-157 is studied for its relationship to new blood vessel formation (angiogenesis) at sites of tissue injury in preclinical models.
Tendon and Ligament Repair Studies
Preclinical studies observe tendon and ligament healing parameters following BPC-157 exposure in animal research models.
Gastrointestinal Tissue Research
Investigational literature examines BPC-157's origins as a compound derived from studies of gastric protective mechanisms.
Anti-Inflammatory Pathway Markers
Studies explore anti-inflammatory markers associated with BPC-157 exposure in research settings.
Nitric Oxide Pathway Studies
Some literature investigates BPC-157's studied relationship to nitric oxide signaling pathways relevant to tissue repair.
Pharmacokinetic Profiling
Studies characterize the stability and pharmacokinetic profile of BPC-157 in preclinical research.
04 — FAQ
Frequently Asked Questions
Ano ba talaga ang BPC-157?
Ang BPC-157 ay isang synthetic pentadecapeptide na nagmula sa protective protein na natuklasan sa gastric juice. Pinag-aaralan ito sa research dahil sa posibleng papel nito sa tissue repair. Educational discussion lang ito, hindi sales o medical advice.
FDA-approved ba ito?
Hindi. Ang BPC-157 ay fully investigational compound na wala pang regulatory approval kahit saan. Karamihan ng literature ay animal-model research pa lamang.
Bakit tinatawag itong "Body Protection Compound"?
Ito ang informal na pangalan nito sa research literature, batay sa unang natuklasang protective effect nito sa gastrointestinal tissue studies.
Pwede ba akong bumili nito dito?
Ang page na ito ay para sa educational purposes lamang. Hindi kami nagbebenta ng peptides dito online — kausapin ang isang lisensyadong healthcare provider para sa tamang gabay.
05 — References
References and Academic Literature
Sikiric, P., et al. (2018). Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract. Current Pharmaceutical Design.
Chang, C.H., et al. (2011). The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Angiogenesis. Journal of Applied Physiology.
Seiwerth, S., et al. (2018). BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Current Pharmaceutical Design.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups